Health Care: Drugs

Valeant Pharmaceuticals International Inc (VRX: NYSE)

$145.45 0.72 | 0.5%
11/28/14 - 01:03 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -863.67M -116.02M 0.00 -208.19M
Operating Gains/Losses 69.37M 8.46M 5.78M 78.39M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -261.38M -219.43M -164.58M 25.19M
(Increase) Decrease in Inventories -122.70M -80.30M -11.52M 7.46M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -76.55M -29.07M -8.98M -76.10M
(Decrease) Increase In Other Current Liabilities 0.00 20.70M 54.68M 17.01M
(Increase) Decrease In Other Working Capital 0.00 0.00 -3.63M -2.82M
Other Non-Cash Items 625.16M 314.40M 410.17M 213.38M
Net Cash From Continuing Operations 1.04B 656.58M 676.47M 263.19M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.04B 656.58M 676.47M 263.19M
Sale of Property, Plant & Equipment 0.00 92.00M 0.00 15.05M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -184.96M -181.13M -385.95M -16.82M
Acquisitions -5.25B -3.49B -2.46B 224.45M
Purchases of Short-Term Investments 0.00 -7.20M -81.09M 0.00
Other Cash from Investing Activities 41.09M -8.87M 0.00 -1.70M
Cash Provided by Financing Activities
Net Cash From Investing Activities -5.38B -2.97B -2.84B 228.94M
Issuance of Debt 8.47B 6.04B 5.39B 992.40M
Cash Used for Financing Activities
Issuance of Capital Stock 10.02M 23.03M 41.74M 58.42M
Repayment of Long-Term Debt -6.40B -2.57B -2.62B -796.38M
Repurchase of Capital Stock -55.63M -280.72M -639.24M -60.13M
Payment of Cash Dividends 0.00 0.00 0.00 -356.29M
Other Financing Charges, Net 2.01B -155.61M -225.02M -51.31M
Net Cash From Financing Activities 4.03B 3.06B 1.95B -213.28M
Effect of Exchange Rate Changes -5.07M 3.76M -10.29M 959.00K
Net Change in Cash & Cash Equivalents -315.75M 751.98M -230.16M 279.81M

Portfolios with VRX

Latest VRX Headlines from TheStreet

More Financial News for VRX

Press Releases for VRX

See All Press Releases

Partner Headlines for VRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter